ARHGEF33: A Potential Drug Target and Biomarker (G100271715)

Target Name: ARHGEF33

NCBI ID: G100271715

ARHGEF33

Other Name(s): ARHGEF33 variant 1 | Rho guanine nucleotide exchange factor (GEF) 33 | Rho guanine nucleotide exchange factor 33 (isoform 1) | Rho guanine nucleotide exchange factor 33 | DH and coiled-coil domain-containing protein ENSP00000381780 | Rho guanine nucleotide exchange factor 33, transcript variant 1 | ARG33_HUMAN

ARHGEF33: A Potential Drug Target and Biomarker

ARHGEF33 is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and kidneys. It is a member of the G-protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a crucial role in cellular signaling. Activation of ARHGEF33 has been shown to have a variety of physiological effects, including modulating pain perception, insulin sensitivity, and inflammation.

Drug Target Potential

The potential drug target for ARHGEF33 is related to its role in pain perception and inflammation. Several studies have shown that activation of ARHGEF33 can enhance pain sensitivity in animals, which suggests that it may be a useful target for pain medications. Additionally, ARHGEF33 has been shown to play a role in modulating inflammation in various tissues, including the brain and the immune system. This suggests that it may be a useful target for anti-inflammatory drugs.

Biomarker Potential

ARHGEF33 may also be a useful biomarker for some diseases. For example, some studies have shown that ARHGEF33 is expressed in the brains of individuals with Alzheimer's disease, which suggests that it may be a useful biomarker for this disease. Additionally, ARHGEF33 has been shown to be involved in insulin sensitivity, which makes it a potential biomarker for type 2 diabetes.

In conclusion

ARHGEF33 is a protein that has been shown to have a variety of physiological effects, including modulating pain perception and inflammation. As a result, it is a potential drug target and biomarker. Further research is needed to fully understand the role of ARHGEF33 in various tissues and conditions.

Protein Name: Rho Guanine Nucleotide Exchange Factor 33

Functions: May act as a guanine-nucleotide releasing factor

The "ARHGEF33 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARHGEF33 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets